Rogaratinib (BAY1163877) is a potent, selective, and orally bioavailable small molecule inhibitor targeting FGFR1, FGFR2, and FGFR3 kinase activity. It is widely used in preclinical research to investigate FGFR-driven pathologies, including in studies of cancer cell proliferation and tumor growth in both cellular and animal models.
Molekulargewicht:
466.56
Reinheit:
99.54% (May vary between batches)
CAS Nummer:
[1443530-05-9]
Formel:
C23H26N6O3S
Target-Kategorie:
FGFR
Anwendungsbeschreibung:
Solubility: DMSO:5.5 mg/mL (11.79 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten